Menstrual Disturbances Not Being Tracked, Treated in Cancer Patients
New research suggests that some cancer patients do not have their menstrual history documented and do not receive treatment for menstrual disturbances.
Diagnosis & Disease Information
MEDI1191 Plus Durvalumab Appears Safe, Active in Advanced Solid Tumors
Combination treatment with MEDI1191 and durvalumab has demonstrated activity in a phase 1 trial of patients with advanced solid tumors.
Cancer Risk Found to Be Higher in Asthma Patients
People with asthma are more likely to develop cancer, particularly those not using inhaled steroids, a study suggests.
Neoadjuvant Vibostolimab Plus Pembrolizumab Demonstrates Activity in Melanoma
Neoadjuvant vibostolimab plus pembrolizumab has shown antitumor activity in a phase 1/2 trial of patients with stage IIIB-D melanoma.
Pembrolizumab May Be Treatment of Choice for Unresectable Desmoplastic Melanoma
In a phase 2 trial, pembrolizumab produced an overall response rate of 89% in patients with unresectable desmoplastic melanoma.
Personalized mRNA Vaccine Prolongs RFS in High-Risk Melanoma
Adding an mRNA vaccine to adjuvant treatment with pembrolizumab prolongs relapse-free survival in high-risk melanoma, a phase 2 study suggests.
Higher Risk of Death for Cancer Diagnosed During Pregnancy or Postpartum
Being diagnosed with cancer during pregnancy or up to 1 year postpartum is associated with an increased risk of death, research suggests.
Pembrolizumab Plus Lenvatinib Miss in Phase 3 Melanoma, Colorectal Cancer Trials
The LEAP-003 trial will be discontinued, and the primary endpoint was not met in the LEAP-017 trial.
Lack of Data to Support ICI Retreatment in Advanced Melanoma
Immune checkpoint inhibitor retreatment in advanced melanoma is used in clinical practice, but there is a lack of evidence to support it, a study suggests.
Hispanic Patients Have Highest Survival Rate After Merkel Cell Carcinoma
Patients with MCC may have different sites of disease, stage at diagnosis, and survival outcomes according to their racial or ethnic group.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...